Andrea E. Wahner Hendrickson
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 23
- Oncology top 5%
- PARP inhibition in cancer therapy 20
-
- PI3K/AKT/mTOR signaling in cancer 5
- Chromatin Remodeling and Cancer 4
-
- Advanced Breast Cancer Therapies 6
-
- Barrier Structure and Function Studies 5
-
- Cancer Mechanisms and Therapy 4
-
- Intraperitoneal and Appendiceal Malignancies 3
- Co-authors
- Scott H. KaufmannKaren S. FlattenLarry M. KarnitzGini F. FlemingCatherine J. HuntoonUrsula A. MatulonisBradley J. MonkAmit M. Oza
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Andrea E. Wahner Hendrickson
50 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Reproductive Medicine 405
- Oncology 839
- Cancer Research 157
- Molecular Biology 633
- Immunology 164
Countries citing papers authored by Andrea E. Wahner Hendrickson
This map shows the geographic impact of Andrea E. Wahner Hendrickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea E. Wahner Hendrickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea E. Wahner Hendrickson more than expected).
Fields of papers citing papers by Andrea E. Wahner Hendrickson
This network shows the impact of papers produced by Andrea E. Wahner Hendrickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea E. Wahner Hendrickson. The network helps show where Andrea E. Wahner Hendrickson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea E. Wahner Hendrickson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 12 | |
| 13 | 2019 | 45 | |
| 14 | Loss of RAD51C promoter hypermethylation confers PARP inhibitor resistance | 2018 | 1 |
| 15 | 2018 | 5 | |
| 16 | 2016 | 25 | |
| 17 | 2016 | 82 | |
| 18 | 2015 | 16 | |
| 19 | 2013 | 158 | |
| 20 | 2009 | 43 |
About Andrea E. Wahner Hendrickson
Andrea E. Wahner Hendrickson is a scholar working on Reproductive Medicine, Oncology and Neurology, having authored 55 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (23 papers), PARP inhibition in cancer therapy (20 papers), Advanced Breast Cancer Therapies (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Barrier Structure and Function Studies (5 papers), Chromatin Remodeling and Cancer (4 papers), Cancer Mechanisms and Therapy (4 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). The work is most often cited by research in Reproductive Medicine (405 citations), Oncology (839 citations) and Cancer Research (157 citations). Andrea E. Wahner Hendrickson has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Scott H. Kaufmann, Karen S. Flatten, Larry M. Karnitz, Gini F. Fleming, Catherine J. Huntoon, Ursula A. Matulonis, Bradley J. Monk, Amit M. Oza, Amelia M. Huehls and Shari L. Sutor.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.